388 related articles for article (PubMed ID: 14517963)
41. Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours.
Prasad BCM; Chandra VVR; Sudarsan A; Kumar PS; Sarma PVGK
J Clin Neurosci; 2018 Jul; 53():62-68. PubMed ID: 29680440
[TBL] [Abstract][Full Text] [Related]
42. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
43. Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Mantripragada KK; Caley M; Stephens P; Jones CJ; Kluwe L; Guha A; Mautner V; Upadhyaya M
Genes Chromosomes Cancer; 2008 Mar; 47(3):238-46. PubMed ID: 18069666
[TBL] [Abstract][Full Text] [Related]
44. Nf1 gene targeting: toward models and mechanisms.
Cichowski K; Shih TS; Jacks T
Semin Cancer Biol; 1996 Oct; 7(5):291-8. PubMed ID: 9110406
[TBL] [Abstract][Full Text] [Related]
45. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
[TBL] [Abstract][Full Text] [Related]
46. Malignant peripheral nerve sheath tumour of the cervical vagus nerve in a neurofibromatosis type 1 patient.
Molina AR; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1458-62. PubMed ID: 17113542
[TBL] [Abstract][Full Text] [Related]
47. Internal tumor burden in neurofibromatosis Type I patients with large NF1 deletions.
Kluwe L; Nguyen R; Vogt J; Bengesser K; Mussotter T; Friedrich RE; Jett K; Kehrer-Sawatzki H; Mautner VF
Genes Chromosomes Cancer; 2012 May; 51(5):447-51. PubMed ID: 22294457
[TBL] [Abstract][Full Text] [Related]
48. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene.
Upadhyaya M; Osborn M; Maynard J; Harper P
Am J Med Genet; 1996 Jul; 67(4):421-3. PubMed ID: 8837715
[TBL] [Abstract][Full Text] [Related]
49. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
[TBL] [Abstract][Full Text] [Related]
50. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.
Wimmer K; Yao S; Claes K; Kehrer-Sawatzki H; Tinschert S; De Raedt T; Legius E; Callens T; Beiglböck H; Maertens O; Messiaen L
Genes Chromosomes Cancer; 2006 Mar; 45(3):265-76. PubMed ID: 16283621
[TBL] [Abstract][Full Text] [Related]
51. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
52. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
[TBL] [Abstract][Full Text] [Related]
53. H-ras-1 point mutation in malignant peripheral nerve sheath tumors: polymerase chain reaction restriction fragment length polymorphism analysis and direct sequencing from paraffin-embedded tissues.
Watanabe T; Sakamoto A; Tamiya S; Oda Y; Masuda K; Tsuneyoshi M
Int J Mol Med; 2000 Jun; 5(6):605-8. PubMed ID: 10812008
[TBL] [Abstract][Full Text] [Related]
54. Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.
Mattox AK; Douville C; Silliman N; Ptak J; Dobbyn L; Schaefer J; Popoli M; Blair C; Judge K; Pollard K; Pratilas C; Blakeley J; Rodriguez F; Papadopoulos N; Belzberg A; Bettegowda C
Elife; 2022 Mar; 11():. PubMed ID: 35244537
[TBL] [Abstract][Full Text] [Related]
55. Elevated risk for MPNST in NF1 microdeletion patients.
De Raedt T; Brems H; Wolkenstein P; Vidaud D; Pilotti S; Perrone F; Mautner V; Frahm S; Sciot R; Legius E
Am J Hum Genet; 2003 May; 72(5):1288-92. PubMed ID: 12660952
[TBL] [Abstract][Full Text] [Related]
56. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.
Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE
Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778
[TBL] [Abstract][Full Text] [Related]
57. Functional analysis of splicing mutations in exon 7 of NF1 gene.
Bottillo I; De Luca A; Schirinzi A; Guida V; Torrente I; Calvieri S; Gervasini C; Larizza L; Pizzuti A; Dallapiccola B
BMC Med Genet; 2007 Feb; 8():4. PubMed ID: 17295913
[TBL] [Abstract][Full Text] [Related]
58. Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.
Sohier P; Luscan A; Lloyd A; Ashelford K; Laurendeau I; Briand-Suleau A; Vidaud D; Ortonne N; Pasmant E; Upadhyaya M
Genes Chromosomes Cancer; 2017 May; 56(5):421-426. PubMed ID: 28124441
[TBL] [Abstract][Full Text] [Related]
59. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
[TBL] [Abstract][Full Text] [Related]
60. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
